Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

The session follows the American Association for Cancer Research's prior call to action against executive orders that would ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout ...